Scientific Founders

Aaron is the Chief Scientific Officer of Akouos, a precision genetic medicines company focused on therapies for people affected by disabling hear loss, which was acquired by Eli Lilly and Company in 2022. Aaron is a board-certified, fellowship-trained surgeon who specializes in the diagnosis and treatment of disorders of the ear and skull base. Prior to Akouos, he was an associate professor at the University of California, San Francisco (UCSF). A surgeon-scientist, Aaron is a pioneer in the application of high-throughput sequencing technologies to critical problems in biomedicine. He has authored more than 30 publications spanning the fields of genomics, cancer biology, stem cell biology, and skull base surgery. He received both a Ph.D. in biomedical sciences and an M.D. from UCSF and completed his residency in otolaryngology-head and neck surgery and a fellowship in otology, neurotology, and skull base surgery at Harvard Medical School. He completed a postdoctoral fellowship at the Broad Institute of MIT and Harvard.